Cargando…

The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients

The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Philip Raj, Pathak, Niteen, Pradhan, Gourango, Sumanlatha, Gaddam, Mukhopadhyay, Sangita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484515/
https://www.ncbi.nlm.nih.gov/pubmed/28651002
http://dx.doi.org/10.1371/journal.pone.0179965
_version_ 1783245897215246336
author Abraham, Philip Raj
Pathak, Niteen
Pradhan, Gourango
Sumanlatha, Gaddam
Mukhopadhyay, Sangita
author_facet Abraham, Philip Raj
Pathak, Niteen
Pradhan, Gourango
Sumanlatha, Gaddam
Mukhopadhyay, Sangita
author_sort Abraham, Philip Raj
collection PubMed
description The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against N-PPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein.
format Online
Article
Text
id pubmed-5484515
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54845152017-07-11 The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients Abraham, Philip Raj Pathak, Niteen Pradhan, Gourango Sumanlatha, Gaddam Mukhopadhyay, Sangita PLoS One Research Article The PPE (proline-proline-glutamic acid) proteins of Mycobacterium tuberculosis are characterized by a conserved N-terminal domain of approximately 180 amino acids and variable C-terminal domain. Since last decade, these proteins have gained much importance in the serodiagnosis of tuberculosis (TB) as they act as a source of antigenic variation. We have demonstrated earlier that one of the PPE proteins PPE17 (Rv1168c) induces strong B-cell and T-cell responses in active TB disease and also displays a higher antibody titer compared to immunodominant antigens such as ESAT-6, Hsp60 and PPD. However, the immunodominant domain of PPE17 (N-terminal or C-terminal) was not examined in detail. In the present study, we observed that antibody responses elicited in TB patients were directed mostly towards the N-terminal domain of PPE17 (N-PPE17). The antibody generated against N-PPE17 in TB patients did not significantly cross-react with N-terminal domains of other PPE proteins used in this study. Our data suggest that the N-terminal domain of PPE17 protein is immunodominant and could be used as a better serodiagnostic marker than the full-length PPE17 protein. Public Library of Science 2017-06-26 /pmc/articles/PMC5484515/ /pubmed/28651002 http://dx.doi.org/10.1371/journal.pone.0179965 Text en © 2017 Abraham et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abraham, Philip Raj
Pathak, Niteen
Pradhan, Gourango
Sumanlatha, Gaddam
Mukhopadhyay, Sangita
The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title_full The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title_fullStr The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title_full_unstemmed The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title_short The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients
title_sort n-terminal domain of mycobacterium tuberculosis ppe17 (rv1168c) protein plays a dominant role in inducing antibody responses in active tb patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484515/
https://www.ncbi.nlm.nih.gov/pubmed/28651002
http://dx.doi.org/10.1371/journal.pone.0179965
work_keys_str_mv AT abrahamphilipraj thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT pathakniteen thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT pradhangourango thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT sumanlathagaddam thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT mukhopadhyaysangita thenterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT abrahamphilipraj nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT pathakniteen nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT pradhangourango nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT sumanlathagaddam nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients
AT mukhopadhyaysangita nterminaldomainofmycobacteriumtuberculosisppe17rv1168cproteinplaysadominantroleininducingantibodyresponsesinactivetbpatients